Filter
1263
Text search:
drug
interactions
Featured
143
297
Language
Document type
707
208
184
72
31
29
24
5
1
1
Countries
65
49
40
34
33
30
25
22
21
20
20
19
17
17
17
16
16
13
13
13
10
10
9
7
7
7
7
7
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
420
131
71
42
30
27
4
Toolboxes
220
148
82
61
59
47
42
30
27
24
22
21
18
16
16
12
8
6
6
4
3
2
2
1
1
The guide presents a structured framework covering assessment and planning, service delivery models, integration with broader health and social services, monitoring, and sustainability. It emphasizes community leadership, human rights, equitable access and adaptation to local contexts, including clo
...
Third edition
Accessed November 2017
Клинический протокол для Европейского региона ВОЗ
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
guidance for health managers, health workers, and activists
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
Nature | Vol 600 | 2 December 2021 |
The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules
- Essential Care and Practice that includes general guid
...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen
...
Treatment Recommendations for Adult Inpatients
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
